Clinical and hemodynamic factors associated with the outcome of early extubation attempts after right heart bypass surgery

Interact Cardiovasc Thorac Surg. 2009 Jun;8(6):624-8. doi: 10.1510/icvts.2008.189431. Epub 2009 Mar 4.

Abstract

Fast-track anesthesia with early extubation (EE) is playing an increasingly important role in pediatric cardiac surgery. We examined the pre- and intra-operative factors contributing to successful EE, and outcomes after right heart bypass surgery (RHB). We retrospectively reviewed the medical records of 71 consecutive children (median age=14 months) admitted over a 4-year period to the pediatric intensive care unit (PICU) of our university-based hospital, after RHB. We compared the characteristics and outcomes of 38 children (54%) extubated <3 h, with those of 33 (46%) extubated >or=3 h after surgery. Odd ratios (OR) and 95% confidence intervals (CI) were calculated. Variables associated with EE included a lower dose of intra-operative fentanyl (OR: 0.95; 95% CI, 0.92-0.99; P=0.03), nitroglycerin (OR: 0.23; 95% CI, 0.07-0.73; P=0.01), and a lower inotropic score (OR: 0.76; 95% CI, 0.61-0.94; P=0.01) on admission. EE was correlated with fewer postoperative respiratory complications (OR: 0.09; 95% CI, 0.02-0.57; P=0.01) and shorter stay in the PICU (OR: 0.88; 95% CI, 0.76-1.03; P=0.12). Our data suggest that EE after RHB could be facilitated in patients with a preserved cardiac function and lower pulmonary vascular resistance. EE could be followed by fewer postoperative pulmonary complications.

Publication types

  • Comparative Study

MeSH terms

  • Analgesics, Opioid / administration & dosage
  • Anesthesia, General / adverse effects
  • Anesthesia, General / methods*
  • Cardiotonic Agents / therapeutic use
  • Female
  • Fentanyl / administration & dosage
  • Heart Bypass, Right*
  • Heart Defects, Congenital / physiopathology
  • Heart Defects, Congenital / surgery*
  • Hemodynamics* / drug effects
  • Humans
  • Infant
  • Intensive Care Units, Pediatric
  • Intubation, Intratracheal* / adverse effects
  • Length of Stay
  • Logistic Models
  • Lung Diseases / etiology
  • Lung Diseases / physiopathology
  • Lung Diseases / prevention & control
  • Male
  • Nitroglycerin / administration & dosage
  • Odds Ratio
  • Respiration, Artificial
  • Retrospective Studies
  • Risk Assessment
  • Time Factors
  • Treatment Outcome
  • Vasodilator Agents / therapeutic use

Substances

  • Analgesics, Opioid
  • Cardiotonic Agents
  • Vasodilator Agents
  • Nitroglycerin
  • Fentanyl